Brief: Cannassure Therapeutics And Lipidor AB To Develop Topical Medical Cannabis Products Based On AKVANO Technology11/12/2019 19:44
Brief: Lipidor And Cannassure Enter Feasibility Study And Licence Option Agreement For Development And Sales Of Topical Medical Cannabis Products10/12/2019 07:29
Brief: Lipidor: Last Patient Out In Calcipotriol/AKVANO Phase III Study Targeting Psoriasis07/11/2019 10:12